Almac Installs Uhlmann Blister Line in New US Commercial Packaging Facility
News Jul 02, 2012
Almac has announced the acquisition of a high-speed blister line for their new 100,000ft2 US commercial packaging facility in Audubon, PA.
The versatile UPS 4 blister line will process solid oral dose products, providing primary packaging into a range of materials including PVC, PVC/PVDC, Aclar and Alu/Alu.
Complete with an integrated C2206 cartoner, the line will provide a highly efficient packaging solution with an output of up to 12,000 blisters per hour - in a wide range of blister sizes.
The line is capable of both multi-product blister processing and online blister printing (both flexographic and digital) addressing the need for enhanced patient compliance, whilst ensuring flexibility of supply.
Enhancing product compliance, the line will include a Total Quality Control Centre (TQCC) incorporating a checkweigher and integrated print and vision system for auto - rejection of incorrect print / serialization data including 2D codes.
The blister line will complement the full suite of highly flexible and state of the art commercial packaging equipment already installed in the new Audubon facility.
Supporting high volume marketed products to niche/orphan drug launches, additional key technologies include bottling, walleting and vial labelling/packaging.
Geoff Sloan, VP Manufacturing Operations explained that the partnership with Uhlmann, one of the leading US pharmaceutical equipment suppliers, was a natural choice: “Uhlmann were able to provide us with a versatile, high-spec blistering line to match our US client requirements for a high quality, flexible commercial packaging solution.”
Ralf Klotz, Regional Sales Manager at Uhlmann, added “the construction and installation of this equipment proved to be a great project. We are looking forward to a long term partnership with Almac as their US Operations continues to grow. The flexibility of this equipment certainly puts Almac in a position as a leader in contract blister packaging”.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE